DCTD Programs
 |
Cancer Diagnosis Program Funds specimen resources and research to characterize tumors |
 |
 |
Radiation Research Program Funds novel radiotherapy research |
 |
Cancer Imaging Program Evaluates imaging in diagnosis, disease staging, and treatment monitoring |
|
 |
Translational Research Program Integrates scientific advancements in the understanding of the biology of human cancer |
 |
Cancer Therapy Evaluation Program Assesses new anticancer agents, radiation treatments, and surgical methods |
|
 |
Biometric Research Branch Provides statistical and biomathematical analyses |
 |
Developmental Therapeutics Program Funds drug discovery and development and provides related services |
|
 |
Office of Cancer Complementary and Alternative Medicine Improves the quality of cancer research on complementary and alternative modalities |
Message from the DCTD Director:
The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on developing novel diagnostics and therapies for cancer. DCTD staff members, along with colleagues throughout the National Cancer Institute (NCI), academia, and industry, are working together to generate More…
News
NCI Chemical Biology Consortium (CBC)
NCI Director Announces New Staff Appointments
Study Shows Reduction in Death for Men with Intermediate-Grade Prostate Cancer
High-Dose Methotrexate Extends Event-Free Survival for Children with Leukemia
Some Women May Not Need More Extensive Lymph Node Surgery for Breast Cancer
Combining Targeted Cancer Therapies: Much Promise, Many Hurdles
DCTD Announces Strategic Research Initiatives
NCI’s Clinical Trials Cooperative Groups
National Meeting Report
